NASDAQ · Analyst Forecast

RenovoRx, Inc. (RNXT) Stock Forecast & Price Target

$1.04 NASDAQ: RNXT Market Cap $50.18M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering RenovoRx, Inc. (RNXT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For RenovoRx, Inc., analysts forecast revenue rising from $1.30M in 2025 to $254.25M in 2030; the average estimate for 2030 earnings per share is $1.57; with published estimates ranging from $1.23 to $2.08; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.18M$1.30M$1.43M3
2026$3.20M$3.85M$4.82M3
2027$9.67M$10.50M$11.33M3
2028$22.91M$32.76M$46.92M3
2029$98.43M$118.45M$148.06M1
2030$211.29M$254.25M$317.82M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.31−$0.28−$0.253
2026−$0.27−$0.26−$0.253
2027−$0.10−$0.09−$0.083
2028$0.03$0.04$0.053
2029$0.45$0.57$0.761
2030$1.23$1.57$2.082

RenovoRx, Inc. (RNXT) forecast — frequently asked questions

What are analysts forecasting for RenovoRx, Inc.'s earnings?

The average analyst estimate for RenovoRx, Inc. (RNXT) earnings per share in 2030 is 1.57, with individual estimates between 1.23 and 2.08.

How much revenue is RenovoRx, Inc. expected to make?

Analysts forecast RenovoRx, Inc. (RNXT) revenue of $254.25M in 2030, based on 2 published estimates.

How many analysts cover RNXT?

3 analysts contribute estimates for RenovoRx, Inc. (RNXT). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.